How A Biotech Startup Became A Mass COVID-19 Testing Lab
Ginkgo BioWorks in Boston expects to be able to process tens of thousands of coronavirus tests a day by early December. Their tech innovations laid the groundwork to get testing up and running quickly.
WBUR’s Carey Goldberg reports.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.